Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	5,072	3,499	2,040	1,556	1,182	959
Market Cap Growth	144.06%	71.56%	31.13%	31.55%	23.36%	219.69%
Enterprise Value	4,542	2,975	1,669	1,125	915	768
PE Ratio	94.47	320.10	-14.57	-22.36	-36.76	-50.22
PS Ratio	52.86	69.02	-	-	-	-
PB Ratio	6.35	4.49	3.91	2.62	4.05	4.72
P/FCF Ratio	111.33	-5803.11	-13.28	-13.38	-28.89	-38.21
P/OCF Ratio	-107.66	-39.40	-20.28	-32.45	-45.33	-51.29
EV/Sales Ratio	47.34	58.68	-	-	-	-
EV/EBITDA Ratio	69.84	166.17	-12.16	-16.99	-30.19	-42.68
EV/EBIT Ratio	76.82	230.69	-11.93	-16.53	-28.45	-40.24
EV/FCF Ratio	99.69	-4933.99	-10.87	-9.68	-22.36	-30.62
Debt / Equity Ratio	0.01	0.01	0.02	0.01	0.01	0.02
Debt / EBITDA Ratio	0.12	0.45	-0.07	-0.12	-0.13	-0.18
Debt / FCF Ratio	0.17	-13.42	-0.06	-0.07	-0.10	-0.13
Quick Ratio	12.29	17.35	13.14	17.02	17.56	58.22
Current Ratio	12.66	17.77	13.30	17.18	17.80	58.88
Asset Turnover	0.12	0.07	0	0	0	0
Interest Coverage	-	-	-	-45.63	-	-
Return on Equity (ROE)	7.70%	1.60%	-25.80%	-15.00%	-11.70%	-10.60%
Return on Assets (ROA)	7.30%	1.50%	-23.80%	-14.20%	-11.20%	-10.30%
Return on Capital (ROIC)	-8.10%	-11.82%	-27.34%	-11.35%	-11.15%	-10.71%
Earnings Yield	1.13%	0.31%	-6.86%	-4.47%	-2.72%	-1.99%
FCF Yield	0.90%	-0.02%	-7.53%	-7.47%	-3.46%	-2.62%
Buyback Yield / Dilution	-13.92%	-8.87%	-14.84%	-18.15%	-18.15%	-41.93%
Total Shareholder Return	-13.92%	-8.87%	-14.84%	-18.15%	-18.15%	-41.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).